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Predictors of Perioperative Blood Loss in
Total Joint Arthroplasty
Jai Hyung Park, MD, PhD, Mohammad R. Rasouli, MD, S.M. Javad Mortazavi, MD, Anthony T. Tokarski, BS,
Mitchell G. Maltenfort, PhD, and Javad Parvizi, MD, FRCS
Investigation performed at the Rothman Institute of Orthopaedics, Philadelphia, Pennsylvania

Background: Despite advances in surgical and anesthetic techniques, lower-extremity total joint arthroplasty is associated with considerable perioperative blood loss. As predictors of perioperative blood loss and allogenic blood transfusion have not yet been well defined, the purpose of this study was to identify clinical predictors for perioperative blood
loss and allogenic blood transfusion in patients undergoing total joint arthroplasty.
Methods: From 2000 to 2008, all patients undergoing unilateral primary total hip or knee arthroplasty who met the
inclusion criteria were enrolled in the study. Perioperative blood loss was calculated with use of a previously validated
formula. The predictors of perioperative blood loss and allogenic blood transfusion were identified in a multivariate
analysis.
Results: Eleven thousand three hundred and seventy-three patients who underwent total joint arthroplasty, including
4769 patients who underwent total knee arthroplasty and 6604 patients who underwent total hip arthroplasty, were
evaluated. Multivariate analysis indicated that an increase in blood loss was associated with being male (263.59 mL in
male patients who had undergone total hip arthroplasty and 233.60 mL in male patients who had undergone total knee
arthroplasty), a Charlson Comorbidity Index of >3 (293.99 mL in patients who had undergone total hip arthroplasty and
167.96 mL in patients who had undergone total knee arthroplasty), and preoperative autologous blood donation (593.51
mL in patients who had undergone total hip arthroplasty and 592.30 mL in patients who had undergone total knee
arthroplasty). In patients who underwent total hip arthroplasty, regional anesthesia compared with general anesthesia
reduced the amount of blood loss. The risk of allogenic blood transfusion increased with the amount of blood loss in the
patients who underwent total hip arthroplasty (odds ratio, 1.43 [95% confidence interval, 1.40 to 1.46]) and the patients
who underwent total knee arthroplasty (odds ratio, 1.47 [95% confidence interval, 1.42 to 1.51]), but the risk of blood
transfusion increased with the Charlson Comorbidity Index only in patients who underwent total knee arthroplasty (odds
ratio, 3.2 [95% confidence interval, 1.99 to 5.15]). The risk of allogenic blood transfusion decreased with preoperative
autologous blood donation in patients who underwent total hip arthroplasty (odds ratio, 0.01 [95% confidence interval,
0.01 to 0.02]) and patients who underwent total knee arthroplasty (odds ratio, 0.02 [95% confidence interval, 0.01 to
0.03]).
Conclusions: This study identified some clinical predictors for blood loss in patients undergoing total joint arthroplasty
that we believe can be used for implementing more effective blood conservation strategies.
Level of Evidence: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

I

n spite of advances in surgical and anesthetic techniques as
well as blood conservation strategies, total joint arthroplasty is still associated with substantial blood loss and

many patients need perioperative blood transfusion1,2. In addition to issues regarding shortages and cost3, allogenic blood
transfusion can be associated with serious complications 4.

Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of
any aspect of this work. One or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months prior to submission of
this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. No
author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what
is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the online version of the
article.
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Allogenic blood transfusion may prolong the duration of
hospital stays5 and may adversely affect the outcomes of surgical patients by increasing the risk of surgical site infection and
periprosthetic joint infection6,7. Therefore, great effort has been
made to reduce the rate of allogenic blood transfusion by implementing various blood conservation strategies to reduce
perioperative blood loss4.
Identifying patients at increased risk of considerable
perioperative blood loss and the need for perioperative blood
transfusion is an important step toward establishing an effective blood management strategy8. Numerous studies have been
performed to identify predictors of transfusion requirement in
patients undergoing total joint arthroplasty9-13. However, only
the role of preoperative hemoglobin as a predictor of transfusion requirement has been well defined12. Few studies have
elucidated predictors of blood loss during total joint arthroplasty14,15, and it is not clear which clinical factors affect
perioperative blood loss in patients undergoing total joint
arthroplasty. The majority of these studies have their own
limitations such as using estimated blood loss and showing a
relatively small sample size. Therefore, the present study was designed and was carried out to identify predictors of blood loss as
well as the transfusion requirement in a large cohort of patients
undergoing total joint arthroplasty with calculated blood loss.
Materials and Methods

A

fter obtaining approval from the institutional review board, we retrospectively reviewed our electronic total joint arthroplasty database to
identify patients undergoing primary total joint arthroplasty from January
2000 to December 2008. Patients who underwent simultaneous bilateral total
joint arthroplasty or revision surgery and cases with acquired or congenital
bleeding disorders were excluded from the study.
Patients’ notes were reviewed to obtain required data including demographics, body mass index (BMI), Charlson Comorbidity Index, type of
anesthesia, preoperative autologous blood donation, allogenic blood transfusion, and preoperative and postoperative hematocrit and hemoglobin levels.
The Charlson Comorbidity Index is frequently used to assess underlying comorbidities. The Charlson Comorbidity Index was originally designed
16,17
to determine the risk of ten-year mortality
. We queried our institutional
database with use of codes of the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) to identify comorbidity items,
17
which have previously been described . Raw scores were then adjusted for age.
During the study period, our institution offered preoperative autologous
blood donation to all patients who were scheduling for total joint arthroplasty
with a hemoglobin level of no less than 11 g/dL or a hematocrit level of at least
33%. Autologous blood usually is donated within thirty days preoperatively.
Perioperative blood loss was calculated with use of a previously vali18
dated formula as described by Rosencher et al. , in which RBC is the acronym
for red blood cells and Hct is the abbreviation for hematocrit:
Total RBC loss ðmLÞ ¼ ½Uncompensated RBC loss ðmLÞ
þ½Compensated RBC loss ðmLÞ
Uncompensated RBC loss ðmLÞ ¼ ½Initial RBC ðmLÞ
 ½Final RBC ðmLÞ
Compensated RBC loss ¼ ½Sum of RBCs received from the
various sources of transfusion

P R E D I C T O R S O F P E R I O P E R AT I V E B L O O D L O S S
T O TA L J O I N T A R T H R O P L A S T Y
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Initial RBC ¼ ½Estimated blood volume ðmLÞ
 ½Initial Hct level ð%Þ at Day  1
Final RBC ðmLÞ ¼ ½Estimated blood volume ðmLÞ
 ½Final Hct level ð%Þ at Day þ 3
The estimated blood volume in milliliters was calculated for women
and men separately with use of the formulas:
Women : ½Body surface area ðm2 Þ 3 2430
Men : ½Body surface area ðm2 Þ 3 2530
where body surface area was calculated as
0:0235 3 ½height ðcmÞ0:42246 3 ½weight ðkgÞ0:51456
Finally, total blood loss at a hematocrit of 35% was obtained with use of
the following equation:
Total blood loss ðmLÞ ¼ ½Total RBC loss ðmLÞ=0:35
The hemoglobin for patients with preoperative autologous blood donation used for the calculation was drawn after the donation.

Statistical Analysis
Separate analyses were performed for patients who had undergone total knee
arthroplasty and those who had undergone total hip arthroplasty. Multiple
linear regression analyses were performed to identify predictors of perioperative hemoglobin drop to control for potential confounders. Multiple regression
models were used to identify predictors of perioperative blood loss. Because
data on total blood loss were skewed toward lower values, a generalized linear
model with a negative binomial family was used to create the models. A linear
link function was used so the model would return intercept and parameter
estimates that would be additive. All variables were included in the model
(sex, age, Charlson Comorbidity Index, BMI, hypertension, diabetes, anemia, preoperative autologous blood donation, type of anesthesia, and preoperative hemoglobin level). BMI, age, and hemoglobin level were included
in the model as continuous variables. Also, logistic regression analysis was
performed to identify independent predictors of allogenic blood transfusion. The
amount of blood loss and the level of hemoglobin drop were also included in the
logistic regression analysis in addition to the above-mentioned variables.
We validated the linear and logistic models with use of 200 bootstrap
samples for the total knee arthroplasty and total hip arthroplasty groups. With
use of this validation method, we used all of the data to generate the models.
Each bootstrap was resampled (with replacement) from the original data set, a
model was generated, and then the performance of this model against the
original data was tested. The correlation coefficient and the mean squared error
for linear regression and the area under the curve for the logistic regression
models were calculated.
All analyses were done with use of R 2.15.1 (R Foundation for Statistical
Computing, Vienna, Austria) using the rms (regression modeling strategies)
package for the logistic regression. In this study, we did not provide a priori
hypotheses for any particular variable and the analyses were designed as
exploratory with a high likelihood of chance findings, so the critical p value
thresholds were adjusted for multiple comparisons. As six multivariate models
were created in this study (three models of blood loss, hemoglobin drop, and
allogenic blood transfusion for the total hip arthroplasty group and the same
three models for the total knee arthroplasty group), using a p value of 0.05, a
Bonferroni-adjusted threshold of 0.0083 was used to assess these models. In
each model, an adjusted p value of 0.05 divided by the number of variables in
each model was considered to be significant.
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TABLE I Characteristics of Study Patients
Characteristics

Total Knee Arthroplasty Group

Total Hip Arthroplasty Group

Sex*
Male
Female

1604 (33.6%)
3165 (66.4%)

3188 (48.3%)
3416 (51.7%)

Age† (yr)

66.0 ± 11.2

62.7 ± 13.5

BMI† (kg/m2)

32.2 ± 6.6

28.5 ± 5.7

Regional anesthesia*

4567 (95.8%)

6344 (96.1)

Charlson Comorbidity Index of >3*

1008 (21.1%)

1315 (19.9%)

Preoperative autologous blood donation*

2840 (59.6%)

4180 (63.3%)

1.0 (1 to 3)

1.1 (1 to 3)

Units of preoperative autologous blood donation‡ (mL)

*The values are given as the number of patients with the percentage in parentheses. †The values are given as the mean and the standard
deviation. ‡The values are given as the mean number of units with the range in parentheses.

Source of Funding
No external funds were received for the preparation of this manuscript.

coronary artery disease (8.7%), diabetes mellitus (7.1%),
and chronic obstructive pulmonary disease (6.1%).

Results
leven thousand three hundred and seventy-three patients
who underwent total joint arthroplasties, including 4769
patients who underwent total knee arthroplasty and 6604
patients who underwent total hip arthroplasty, were evaluated for this study. The mean patient age (and standard
deviation) was 66.0 ± 11.2 years for those undergoing total
knee arthroplasty and 62.7 ± 13.5 years for those undergoing
total hip arthroplasty. Table I demonstrates the characteristics
of the study patients. The most frequent comorbidities in the
entire cohort were anemia (36.7%), hypertension (32.8%),

Calculated Blood Loss and Hemoglobin Drop
The mean total calculated blood loss (and standard deviation)
was 2181.4 ± 931.1 mL for patients undergoing total knee
arthroplasty compared with 2363.3 ± 1124.7 mL for patients
undergoing total hip arthroplasty. Multivariate analysis indicated that the amount of blood loss was increased by male sex
(263.59 mL in patients who underwent total hip arthroplasty
and 233.60 mL in patients who underwent total knee arthroplasty),
a Charlson Comorbidity Index of >3 (293.99 mL in patients
who underwent total hip arthroplasty and 167.96 mL in patients
who underwent total knee arthroplasty), and preoperative

E

TABLE II Results of Multivariate Analysis to Determine Predictors of Blood Loss in Study Patients
Total Hip Arthroplasty Group
Variable

Estimate*

Total Knee Arthroplasty Group

P Value†

Estimate*

P Value†

Intercept‡

1285.22 ± 217.79

<0.0001

1606.02 ± 235.57

<0.0001

Male sex

263.59 ± 27.15

<0.0001

233.60 ± 29.70

<0.0001

Charlson Comorbidity Index >3

293.99 ± 37.28

<0.0001

167.96 ± 31.42

<0.0001

Age per year

3.44 ± 1.03

0.0008

0.43 ± 1.09

0.69

BMI per unit

12.45 ± 1.96

<0.0001

20.77 ± 1.79

0.66

Hypertension
Diabetes
Anemia
Preoperative autologous blood donation
Regional anesthesia
Preoperative hemoglobin per unit

22.52 ± 27.55

0.41

105.56 ± 26.87

<0.0001

222.48 ± 58.35

0.70

251.84 ± 46.65

0.26

91.66 ± 39.33

0.02

20.97 ± 39.15

0.59

593.51 ± 24.60

<0.0001

592.30 ± 24.85

<0.0001

2326.97 ± 68.20

<0.0001

280.98 ± 61.03

0.18

8.28 ± 14.67

0.57

16.44 ± 13.77

0.23

*The values are given as the estimate and the standard error in milliliters. †Significant values were set at p < 0.005. ‡This category denotes the
mean expected estimate without considering other variables.
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TABLE III Multivariate Analysis to Determine Predictors of Hemoglobin Drop in Patients Undergoing Total Joint Arthroplasty
Total Hip Arthroplasty Group
Variable

Estimate*

P Value†

Total Knee Arthroplasty Group
Estimate*

P Value†

Intercept‡

23.84 ± 0.34

<0.0001

22.74 ± 0.32

<0.0001

Male sex

20.09 ± 0.04

0.02

20.22 ± 0.04

<0.0001

Charlson Comorbidity Index of >3

20.08 ± 0.06

0.15

0.01 ± 0.04

Age per year

0.00 ± 0.00

0.77

0.00 ± 0.00

BMI per unit

20.01 ± 0.00

<0.0001

Hypertension

20.07 ± 0.04

0.12

0.05 ± 0.04

0.14

Diabetes

0.04 ± 0.09

0.61

20.04 ± 0.06

0.55

Anemia

0.05 ± 0.06

0.38

20.05 ± 0.05

0.31

20.02 ± 0.00

0.87
0.03
<0.0001

Preoperative autologous blood donation

20.18 ± 0.04

<0.0001

20.19 ± 0.03

<0.0001

Regional anesthesia

20.08 ± 0.09

0.38

20.20 ± 0.08

0.01

Preoperative hemoglobin per unit

0.57 ± 0.02

<0.0001

0.49 ± 0.02

<0.0001

*The values are given as the estimate and the standard error in grams per deciliter. †Significance was set at p < 0.005. ‡This category denotes
the mean estimate for blood loss without considering any other variable included in the model.

autologous blood donation (593.51 mL in patients who underwent total hip arthroplasty and 592.30 mL in patients who
underwent total knee arthroplasty). In patients who have undergone total hip arthroplasty, multivariate analysis also showed
that the amount of blood loss rises by increasing age (3.44 mL
per one-year increase) and BMI (12.45 mL per 1-kg/m2 increase). In patients undergoing total hip arthroplasty, regional
anesthesia compared with general anesthesia reduced the amount
of blood loss by 326.97 mL (Table II). Each model was significant
overall (p < 0.0001), although the predictive value of both models
is poor: the correlation coefficient between prediction and actual

observations was 0.12 for patients who underwent total hip
arthroplasty and 0.08 for patients who underwent total knee
arthroplasty. As each model has ten parameters, a Bonferroni
adjustment for multiple comparisons indicates that only p values
of 0.005 should be considered significant within each model.
The mean postoperative hemoglobin drop (and standard
deviation) after the surgery was 3.0 ± 1.2 g/dL for patients
undergoing total knee arthroplasty and 3.1 ± 1.6 g/dL for
patients undergoing total hip arthroplasty. The results of
the multivariate analysis of the amount of hemoglobin drop
in patients undergoing total hip arthroplasty and patients

TABLE IV Logistic Regression Analysis to Identify Predictors of Allogenic Blood Transfusion in Study Patients
Total Hip Arthroplasty Group
Variable

Odds Ratio*

P Value†

Total Knee Arthroplasty Group
Odds Ratio*

P Value†

Male sex

0.30 (0.22 to 0.43)

<0.0001

0.21 (0.12 to 0.37)

<0.0001

Charlson Comorbidity Index >3

1.22 (0.81 to 1.83)

0.34

3.20 (1.99 to 5.15)

<0.0001

Age per year

1.03 (1.02 to 1.05)

0.0008

1.02 (1.00 to 1.04)

0.88

BMI per unit

0.91 (0.89 to 0.93)

<0.0001

0.90 (0.87 to 0.93)

<0.0001

Hypertension

1.44 (1.04 to 1.99)

0.026935

1.74 (1.10 to 2.74)

0.02

Diabetes

0.96 (0.50 to 1.86)

0.90

0.95 (0.47 to 1.92)

0.88

Anemia

1.24 (0.77 to 2.02)

0.48

1.23 (0.61 to 2.48)

0.56

Preoperative autologous blood donation

0.01 (0.01 to 0.02)

<0.0001

0.02 (0.01 to 0.03)

<0.0001

Regional anesthesia

0.78 (0.42 to 1.47)

0.45

2.40 (0.96 to 6.02)

0.062

Preoperative hemoglobin per unit

0.65 (0.53 to 0.80)

<0.0001

0.55 (0.40 to 0.76)

0.0003

Total blood loss per 100 units

1.43 (1.40 to 1.46)

<0.0001

1.47 (1.42 to 1.51)

<0.0001

Hemoglobin drop per unit

0.23 (0.20 to 0.27)

<0.0001

0.22 (0.18 to 0.28)

<0.0001

*The values are given as the odds ratio, with the 95% CI in parentheses. †Significance was set at p < 0.004.
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undergoing total knee arthroplasty have been summarized in
Table III. Compared with a Bonferroni-adjusted threshold of
p = 0.0083 for the six multivariate models used in this study,
both models are significant (p < 0.0001). For the ten explanatory
variables within each model, the Bonferroni-adjusted threshold
is p = 0.005. For the total hip arthroplasty regression, the
correlation coefficient is 0.22 and the mean squared error is
2.17; after correcting for optimism (200 bootstrap samples),
the correlation coefficient is 0.21 and the mean squared error
is still 2.17. For the total knee arthroplasty model, the correlation coefficient is 0.28 and the mean squared error is
1.14; after correction for optimism (200 bootstrap samples),
the correlation coefficient is still 0.28 and the mean squared
error is 1.15.
Allogenic Blood Transfusion
A total number of 698 patients (14.6%) in the total knee
arthroplasty group and 1171 patients (17.7%) in the total hip
arthroplasty group received allogenic blood transfusion. Logistic regression analysis showed that the risk of allogenic blood
transfusion increased with the amount of blood loss in patients
who underwent total hip arthroplasty (odds ratio [OR], 1.43
[95% confidence interval (CI), 1.40 to 1.46]) and patients who
underwent total knee arthroplasty (OR, 1.47 [95% CI, 1.42 to
1.51]) and with the Charlson Comorbidity Index in patients
who underwent total knee arthroplasty (OR, 3.2 [95% CI, 1.99
to 5.15]). Preoperative autologous blood donation decreased
the risk of allogenic blood transfusion in patients who underwent total hip arthroplasty (OR, 0.01 [95% CI, 0.01 to 0.02])
and patients who underwent total knee arthroplasty (OR, 0.02
[95% CI, 0.01 to 0.03]) (Table IV). The predictive power of
these models was high; the area under the curve was 0.989
for the total hip arthroplasty model and 0.994 for the total
knee arthroplasty model. The correction for optimism with
use of 200 bootstrap samples only reduced this performance
slightly (0.989 for the total hip arthroplasty model and 0.994
for the total knee arthroplasty model). Each model was significant overall (p < 0.0001). The Bonferroni-adjusted threshold
for significance for the twelve parameters in each model was
p = 0.004.
Discussion
n spite of advances in surgical and anesthetic techniques,
blood loss during total joint arthroplasty can be substantial2.
The majority of previous studies regarding blood loss in total
joint arthroplasty use estimated blood loss, which does not
consider ‘‘hidden’’ blood loss, including loss due to extravasation into the tissues; residual blood in the joint; and loss due
to hemolysis, hematoma formation, or bleeding around the
prosthesis19. The amount of blood loss in total joint arthroplasty can be substantial. Both the total knee arthroplasty and
total hip arthroplasty cohorts had >2 L of calculated blood
loss. The calculated blood loss in our study was relatively close
to that in the study by Rosencher et al.18. They showed that
calculated blood loss was significantly higher (1944 mL for
patients who underwent total hip arthroplasty and 1934 mL

I
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for patients who underwent total knee arthroplasty) compared with estimates (750 mL for patients who underwent
total hip arthroplasty and 800 mL for patients who underwent
total knee arthroplasty). Sehat et al.19 showed a mean blood
loss of 1510 mL in patients who underwent total hip arthroplasty and 1498 mL in patients who underwent a total knee
arthroplasty and a total blood loss from wound drainage of
74% in patients who underwent total hip arthroplasty and
51% in patients who underwent a total knee arthroplasty. The
remainder of hidden blood loss was hypothesized to be from
considerable bleeding within the soft tissue. In our study, we
did not calculate either intraoperative blood loss or hidden
blood loss, which is equal to the total blood loss minus the
intraoperative and postoperative blood loss. The estimated
intraoperative and postoperative blood loss is usually small,
consisting of a small proportion of the total blood loss. Although we did not have data on the estimated intraoperative
blood loss for patients in our study to compare and to calculate hidden blood loss, considering the large amount of
perioperative blood loss in the patients in our study, hidden
blood loss was estimated to be large in our patients. As drains
are not used routinely at our institution for patients undergoing total joint arthroplasty, we believe that there was considerable bleeding that occurred within the joint and soft
tissues postoperatively. The hemoglobin level in our study was
also in the range that has been shown in previous studies. The
mean hemoglobin drop (and standard deviation) after surgery was 3.0 ± 1.2 g/dL for patients who underwent total knee
arthroplasty and 3.1 ± 1.6 g/dL for patients who underwent
total hip arthroplasty. The average hemoglobin drop after
primary total joint arthroplasty in our study was similar to
that in the study by Rosencher et al., which showed a mean
hemoglobin drop of 2.8 g/dL18.
Consistent with previous studies12,20, we found that preoperative hemoglobin level is a predictor of allogenic blood
transfusion. The present study also showed that preoperative
autologous blood donation reduces exposure to allogenic blood
in patients undergoing lower-extremity total joint arthroplasty
as previously described in some studies on patients undergoing
total joint arthroplasty2,21. However, it should not be interpreted
that preoperative autologous blood donation reduced all sources
of blood transfusion or perioperative blood loss. Results of two
meta-analyses regarding the effect of preoperative autologous
blood donation on the need for blood transfusion showed that
preoperative autologous blood donation not only reduces
exposure to allogenic blood but also may increase exposure to
all red blood cell transfusion in some types of surgical procedures, such as total joint arthroplasty22,23. This happens because
preoperative autologous blood donation decreases the preoperative hemoglobin level, which is the most important predictor of perioperative blood transfusion. In the present study,
preoperative autologous blood donation was paradoxically
identified as an independent predictor for blood loss. Although
we do not know the exact reason for this finding, similar to
our study, Billote and colleagues also found that in patients
undergoing total hip arthroplasty, the estimated mean blood
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loss (and standard deviation) was higher in autologous blood
donors (4991 ± 1042 mL) compared with non-donors (4631
± 1108 mL)24. They suggested that autologous donors were
healthier and larger, which biased the study. In our study, we
used multivariate analysis to control for the potential confounders.
In this model, preoperative autologous blood donation and the
Charlson Comorbidity Index were independently associated with
increased blood loss while BMI had a negligible effect on perioperative blood loss. Therefore, the significantly higher blood
loss in autologous blood donors in our series cannot be explained
by the health status and larger body size of donors. Preoperative
autologous blood donation has lost favor in many institutions, given the questions about cost and benefit and the use
of tranexamic acid. However, although preoperative autologous
blood donation is currently offered less frequently at our institution compared with the study period, it is still offered to
patients who are scheduling a total joint arthroplasty. On the
basis of our cohort, preoperative autologous blood donation
is effective in reducing exposure to allogenic blood.
The health status of patients undergoing total joint
arthroplasty, which was evaluated by the use of the American
Society of Anesthesiologists (ASA) physical status classification system, is a predictor of blood loss25. Grosflam et al. reported
that being male, receiving general anesthesia, and having an ASA
score of 3 can predict greater total blood loss in patients undergoing total hip arthroplasty25. In the present study, we used
the Charlson Comorbidity Index as an indicator for comorbidities and found that a Charlson Comorbidity Index of >3 is a
predictor of blood loss in patients undergoing total knee
arthroplasty and patients undergoing total hip arthroplasty.
Consistent with previous studies, we showed that perioperative
blood loss is greater in male patients25-28. In spite of being a predictor of blood loss, male sex was a protective factor against
allogenic blood transfusion. Although many factors may
contribute to this finding, it could be explained by the higher
level of preoperative hemoglobin in male patients compared
with female patients as previously reported14.
The role of regional anesthesia in reducing blood loss
during total joint arthroplasty has been well defined29,30. When
using spinal anesthesia, the blockade of preganglionic sympathetic nerves affects the vascular smooth muscles and leads to
vasodilatation of arterioles, arteries, and veins. A generalized
loss of tone of the vascular tree secondary to this sympathetic
denervation occurs. As a result, peripheral resistance, especially
in the region affected by the spinal anesthesia, decreases.
Consequently, blood pressure decreases and the vasomotor
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paralysis and atony result in bleeding that is slow and can be
controlled easily31,32. By considering the role of controlled
hypotensive anesthesia in reducing intraoperative blood loss,
hypertension may increase blood loss, as was found in this
study.
The main limitations of this study related to a lack of data
on preoperative medications and the use of other blood conservation strategies other than preoperative autologous blood
donation and deep vein thrombosis prophylaxis, which can
potentially affect the amount of perioperative blood loss. Although tranexamic acid has routinely been used in our institute
in recent years, at the time of this study, it was not in routine
use and its potential effect on the study results is negligible. We
also do not have data on triggers of blood transfusion in the
study patients. Generally, a postoperative hemoglobin level of
8 g/dL is considered as a trigger for blood transfusion at our
institution. A higher level of hemoglobin may be considered
in the presence of hypovolemia symptoms or in patients with
underlying cardiac disease. If a patient required blood transfusion, and autologous blood had been collected, autologous blood
was typically initially transfused. However, this policy was not
followed in all cases.
In conclusion, our study showed that blood loss during
total joint arthroplasty is substantial despite using various blood
conservation strategies and advances in surgical and anesthetic
techniques. Our results showed that although preoperative autologous blood donation reduces exposure to allogenic blood
transfusion, it may increase perioperative blood loss. We believe
that the results of this study can be used to identify patients who
are at an increased risk for large perioperative blood loss and
exposure to allogenic blood transfusion during total joint
arthroplasty to implement more effective perioperative blood
conservation strategies. n
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Update
The print version of this article has errors that have been corrected in the online version of this article. In the Materials and Methods
section, the sentence that reads as ‘‘During the study period, our institution offered preoperative autologous blood donation to all
patients who were scheduling for total joint arthroplasty with a hemoglobin level of no less than 11 mg/dL or a hematocrit level of at
least 33%.’’ in the print version now reads as ‘‘During the study period, our institution offered preoperative autologous blood
donation to all patients who were scheduling for total joint arthroplasty with a hemoglobin level of no less than 11 g/dL or a
hematocrit level of at least 33%.’’ in the online version. In Table III, the footnote that reads as ‘‘The values are given as the estimate
and the standard error in milligrams per deciliter.’’ in the print version now reads as ‘‘The values are given as the estimate and the
standard error in grams per deciliter.’’ in the online version.
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